Abstract:Human noroviruses (huNoVs), which cause epidemic acute gastroenteritis, recognize histo-blood group antigens (HBGAs) as host attachment factors affecting host susceptibility. HuNoVs are genetically diverse, containing at least 31 genotypes in the two major genogroups (genogroup I [GI] and GII). Three GII genotypes, GII genotype 17 (GII.17), GII.13, and GII.21, form a unique genetic lineage, in which the GII.17 genotype retains the conventional GII HBGA binding site (HBS), while the GII.13/21 genotypes acquire a completely new HBS. To understand the molecular bases behind these evolutionary changes, we solved the crystal structures of the HBGA binding protruding domains of (i) an early GII.17 variant (the 1978 variant) that does not bind or binds weakly to HBGAs, (ii) the new GII.17 variant (the 2014/15 variant) that binds A/B/H antigens strongly via an optimized GII HBS, and (iii) a GII.13 variant (the 2010 variant) that binds the Lewis a (Lea) antigen via the new HBS. These serial, high-resolution structural data enable a comprehensive structural comparison to understand the evolutionary changes of the GII.17/13/21 lineage, including the emergence of the new HBS of the GII.13/21 sublineage and the possible HBS optimization of the recent GII.17 variant for an enhanced HBGA binding ability. Our study elucidates the structural adaptations of the GII.17/13/21 lineage through distinct evolutionary paths, which may allow a theory explaining huNoV adaptations and evolutions to be put forward. IMPORTANCE Our understanding of the molecular bases behind the interplays between human noroviruses and their host glycan ligands, as well as their evolutionary changes over time with alterations in their host ligand binding capability and host susceptibility, remains limited. By solving the crystal structures of the glycan ligand binding protruding (P) domains with or without glycan ligands of three representative noroviruses of the GII.17/13/21 genetic lineage, we elucidated the molecular bases of the human norovirus-glycan interactions of this special genetic lineage. We present solid evidence on how noroviruses of this genetic lineage evolved via different evolutionary paths to (i) optimize their glycan binding site for higher glycan binding function and (ii) acquire a completely new glycan binding site for new ligands. Our data shed light on the mechanism of the structural adaptations of human noroviruses through different evolutionary paths, facilitating our understanding of human norovirus adaptations, evolutions, and epidemiology.

Structural basis of glycan interaction in gastroenteric viral pathogens

Glycan Nanostructures of Human Coronaviruses

Glycan Recognition in Human Norovirus Infections

Virus recognition of glycan receptors

Fondness for sugars of enteric viruses confronts them with human glycans genetic diversity

Structural Basis for the Recognition of Blood Group Trisaccharides by Norovirus

Structural Adaptations of Norovirus GII.17/13/21 Lineage Through Two Distinct Evolutionary Paths

The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding

Exploitation of glycosylation in enveloped virus pathobiology

Glycosphingolipids as receptors for non-enveloped viruses

Glycosylation of viral proteins: Implication in virus–host interaction and virulence

Sialoglycovirology of Lectins: Sialyl Glycan Binding of Enveloped and Non-enveloped Viruses

Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens.

Structural insight of cell surface sugars in viral infection and human milk glycans as natural antiviral substance

Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody

Functional and Structural Characterization of Norovirus GII.6 in Recognizing Histo-blood Group Antigens

Relevance of Host Cell Surface Glycan Structure for Cell Specificity of Influenza A Viruses

Characterization of a Novel Conformational GII.4 Norovirus Epitope: Implications for Norovirus-Host Interactions

The underlying mechanisms of arenaviral entry through matriglycan

Human group C rotavirus VP8*s recognize type A histo-blood group antigens as ligands.